Cargando…

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

Detalles Bibliográficos
Autores principales: Fan, Mingming, Xiao, Huijuan, Song, Dingyun, Zhu, Lili, Zhang, Jie, Zhang, Xinran, Wang, Jing, Dai, Huaping, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890144/
https://www.ncbi.nlm.nih.gov/pubmed/36744209
http://dx.doi.org/10.3389/fphar.2022.1109002
_version_ 1784880891110096896
author Fan, Mingming
Xiao, Huijuan
Song, Dingyun
Zhu, Lili
Zhang, Jie
Zhang, Xinran
Wang, Jing
Dai, Huaping
Wang, Chen
author_facet Fan, Mingming
Xiao, Huijuan
Song, Dingyun
Zhu, Lili
Zhang, Jie
Zhang, Xinran
Wang, Jing
Dai, Huaping
Wang, Chen
author_sort Fan, Mingming
collection PubMed
description
format Online
Article
Text
id pubmed-9890144
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98901442023-02-02 Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization Fan, Mingming Xiao, Huijuan Song, Dingyun Zhu, Lili Zhang, Jie Zhang, Xinran Wang, Jing Dai, Huaping Wang, Chen Front Pharmacol Pharmacology Frontiers Media S.A. 2023-01-18 /pmc/articles/PMC9890144/ /pubmed/36744209 http://dx.doi.org/10.3389/fphar.2022.1109002 Text en Copyright © 2023 Fan, Xiao, Song, Zhu, Zhang, Zhang, Wang, Dai and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fan, Mingming
Xiao, Huijuan
Song, Dingyun
Zhu, Lili
Zhang, Jie
Zhang, Xinran
Wang, Jing
Dai, Huaping
Wang, Chen
Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
title Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
title_full Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
title_fullStr Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
title_full_unstemmed Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
title_short Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
title_sort corrigendum: a novel n-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ask1-p38 pathway and regulating macrophage polarization
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890144/
https://www.ncbi.nlm.nih.gov/pubmed/36744209
http://dx.doi.org/10.3389/fphar.2022.1109002
work_keys_str_mv AT fanmingming corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT xiaohuijuan corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT songdingyun corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhulili corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhangjie corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhangxinran corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT wangjing corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT daihuaping corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT wangchen corrigendumanovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization